The US government has provided almost $24 million in funding to Locus Biosciences to support a mid-stage trial of LBP-EC01, a CRISPR-engineered bacteriophage therapy in development for resistant ...

Meet the jumbo phage. Scientists believe they’ve cracked the code on how its ‘secret handshakes’ act as a shield against the ...

Their potential as antibacterial agents was appreciated almost immediately, with the first 'phage therapy' trials predating Fleming's discovery of penicillin by approximately a decade. In this ...

In the face of rising concerns about antibiotic resistant infections, an international group of microbial experts have launched a powerful and flexible free online genomic toolkit for more rapid ...

Pseudomonas bacteria infected by different mutations of a jumbo phage. The dot in the middle is the shield created by the ...

A CRISPR-based system that erases itself from fly populations may offer a safer approach to tackling insecticide resistance while minimizing ecological risks.

Develop custom oligo design pipelines.

Thurston was a co-founder of Spirogen, whose payload technology is being used in ADC Therapeutics' recently-approved lymphoma therapy Zynlonta (loncastuximab tesirine). Meanwhile, Pheon has also ...